施贵宝 BMY 深 沪
等待开盘 12-20 09:30:00 美东时间
54.135
+0.800
+1.50%
华盛通- 最 高54.855
- 今 开53.425
- 成交量 1518.76万股
- 最 低 48.10
- 昨 收 53.335
- 总市值 1152.53亿
- 52周最高 63.15
- 市盈率 静 17.38
- 换手率 0.71%
- 52周最低 42.52
- 委 比 -45.37%
- 总股本 21.29亿
- 历史最高 81.435
- 量 比 1.10
- 振 幅 12.67%
- 历史最低 7.98
- 每 手 1
- 风险率 5.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
今天 04:17
Takeda's Once-Daily Psoriasis Pill Hits Phase 3 Goals, Beats Amgen's Drug
Takeda reports positive Phase 3 data for psoriasis drug zasocitinib, beating placebo and Otezla, with rapid PASI responses and FDA filing plans.
12-19 03:10
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
12-18 23:14
Bristol Myers' Cancer Breakthrough Breyanzi Just Won Its Fifth FDA Approval
FDA approves Breyanzi, a CAR T cell therapy for relapsed or refractory marginal zone lymphoma. It has a high response rate.
12-05 21:36
Bristol Myers Squibb To Enroll Additional Patients In ADEPT-2 Study
Study Continuation Follows Review of Site Level Data and Recommendation of Data Monitoring CommitteeBMS Remains Blinded to Study DataBristol Myers Squibb (NYSE:BMY, "BMS"))) today announced that it will enroll additional
12-03 20:00
Texas Attorney General Paxton Sues Big Pharma Companies Bristol-Myers Squibb And Sanofi For Making Billions While Harming Americans And Failing To Disclose Plavix's Ineffectiveness
https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-sues-big-pharma-companies-bristol-myers-squibb-and-sanofi-making-billions
11-21 04:54
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership
BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost optimization.
11-03 23:29
Cleveland-Cliffs, Meta And Rocket On CNBC's 'Final Trades'
Cleveland-Cliffs shares gained 1.4% to close at $12.43 on Friday while Bristol-Myers Squibb shares gained 1% to close at $46.07.
11-03 21:12
Bristol Myers Squibb Launches $7B Debt Buyback Program To Manage Outstanding Notes
Bristol-Myers Squibb Company (NYSE:BMY) ("Bristol Myers Squibb" or the "Offeror"), announced the commencement of tender offers ("Offers") to purchase for cash certain of its outstanding notes (collectively, the "Notes")
11-03 18:00
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
10-31 01:40
公司简介
公司名称
|
施贵宝
|
行业分类
|
制药
|
业务描述
|
百时美施贵宝是一家以“研发并提供创新药物，帮助患者战胜严重疾病”为使命的全球性生物制药公司。公司拥有约25000名员工。2016年，百时美施贵宝全球研发投入达近50亿美元，占全年产品净销售额的28%。
|
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
今天 04:17
Takeda's Once-Daily Psoriasis Pill Hits Phase 3 Goals, Beats Amgen's Drug
Takeda reports positive Phase 3 data for psoriasis drug zasocitinib, beating placebo and Otezla, with rapid PASI responses and FDA filing plans.
12-19 03:10
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
12-18 23:14
Bristol Myers' Cancer Breakthrough Breyanzi Just Won Its Fifth FDA Approval
FDA approves Breyanzi, a CAR T cell therapy for relapsed or refractory marginal zone lymphoma. It has a high response rate.
12-05 21:36
Bristol Myers Squibb To Enroll Additional Patients In ADEPT-2 Study
Study Continuation Follows Review of Site Level Data and Recommendation of Data Monitoring CommitteeBMS Remains Blinded to Study DataBristol Myers Squibb (NYSE:BMY, "BMS"))) today announced that it will enroll additional
12-03 20:00
Texas Attorney General Paxton Sues Big Pharma Companies Bristol-Myers Squibb And Sanofi For Making Billions While Harming Americans And Failing To Disclose Plavix's Ineffectiveness
https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-sues-big-pharma-companies-bristol-myers-squibb-and-sanofi-making-billions
11-21 04:54
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership
BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost optimization.
11-03 23:29
Cleveland-Cliffs, Meta And Rocket On CNBC's 'Final Trades'
Cleveland-Cliffs shares gained 1.4% to close at $12.43 on Friday while Bristol-Myers Squibb shares gained 1% to close at $46.07.
11-03 21:12
Bristol Myers Squibb Launches $7B Debt Buyback Program To Manage Outstanding Notes
Bristol-Myers Squibb Company (NYSE:BMY) ("Bristol Myers Squibb" or the "Offeror"), announced the commencement of tender offers ("Offers") to purchase for cash certain of its outstanding notes (collectively, the "Notes")
11-03 18:00
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
10-31 01:40
派息除权日
|
每股总股息
| 派息日期 |
2022-06-30
|
0.54
|
2022-08-01
|
2022-03-31
|
0.54
|
2022-05-02
|
2022-01-06
|
0.54
|
2022-02-01
|
2021-09-30
|
0.49
|
2021-11-01
|
2021-07-01
|
0.49
|
2021-08-02
|
2021-03-31
|
0.49
|
2021-05-03
|
2020-12-31
|
0.49
|
2021-02-01
|
2020-10-01
|
0.45
|
2020-11-02
|
2020-07-02
|
0.45
|
2020-08-03
|
2020-04-02
|
0.45
|
2020-05-01
|
2020-01-02
|
0.45
|
2020-02-03
|
2019-10-03
|
0.41
|
2019-11-01
|
2019-07-03
|
0.41
|
2019-08-01
|
2019-04-04
|
0.41
|
2019-05-01
|
2019-01-03
|
0.41
|
2019-02-01
|
2018-10-04
|
0.40
|
2018-11-01
|
2018-07-05
|
0.40
|
2018-08-01
|
2018-04-05
|
0.40
|
2018-05-01
|
2018-01-04
|
0.40
|
2018-02-01
|
2017-10-05
|
0.39
|
2017-11-01
|
2017-07-05
|
0.39
|
2017-08-01
|
2017-04-05
|
0.39
|
2017-05-01
|
2017-01-04
|
0.39
|
2017-02-01
|
2016-10-05
|
0.38
|
2016-11-01
|
2016-06-29
|
0.38
|
2016-08-01
|
2016-03-30
|
0.38
|
2016-05-02
|
2015-12-30
|
0.38
|
2016-02-01
|
2015-09-30
|
0.37
|
2015-11-02
|
2015-07-01
|
0.37
|
2015-08-03
|
2015-04-01
|
0.37
|
2015-05-01
|
2014-12-30
|
0.37
|
2015-02-02
|
2014-10-01
|
0.36
|
2014-11-03
|
2014-07-01
|
0.36
|
2014-08-01
|
2014-04-02
|
0.36
|
2014-05-01
|
2013-12-31
|
0.36
|
2014-02-03
|
2013-10-02
|
0.35
|
2013-11-01
|
2013-07-02
|
0.35
|
2013-08-01
|
2013-04-03
|
0.35
|
2013-05-01
|
2013-01-02
|
0.35
|
2013-02-01
|
2012-10-03
|
0.34
|
2012-11-01
|
2012-07-03
|
0.34
|
2012-08-01
|
2012-04-03
|
0.34
|
2012-05-01
|
2012-01-04
|
0.34
|
2012-02-01
|
2011-10-06
|
0.33
|
2011-11-01
|
2011-06-29
|
0.33
|
2011-08-01
|
2011-03-30
|
0.33
|
2011-05-02
|
2011-01-05
|
0.33
|
2011-02-01
|
2010-09-29
|
0.32
|
2010-11-01
|
2010-06-30
|
0.32
|
2010-08-02
|
2010-03-30
|
0.32
|
2010-05-03
|
2009-12-30
|
0.32
|
2010-02-01
|
2009-09-30
|
0.31
|
2009-11-02
|
2009-07-01
|
0.31
|
2009-08-03
|
2009-04-01
|
0.31
|
2009-05-01
|
2008-12-30
|
0.31
|
2009-02-02
|
2008-10-01
|
0.31
|
2008-11-03
|
2008-07-02
|
0.31
|
2008-08-01
|
2008-04-02
|
0.31
|
2008-05-01
|
2008-01-02
|
0.31
|
2008-02-01
|
2007-10-03
|
0.28
|
2007-11-01
|
2007-07-03
|
0.28
|
2007-08-01
|
2007-04-03
|
0.28
|
2007-05-01
|
2007-01-03
|
0.28
|
2007-02-01
|
2006-10-04
|
0.28
|
2006-11-01
|
2006-07-05
|
0.28
|
2006-08-01
|
2006-04-05
|
0.28
|
2006-05-01
|
2006-01-04
|
0.28
|
2006-02-01
|
2005-10-05
|
0.28
|
2005-11-01
|
2005-06-29
|
0.28
|
2005-08-01
|
2005-03-30
|
0.28
|
2005-05-02
|
2005-01-05
|
0.28
|
2005-02-01
|
2004-09-29
|
0.28
|
2004-11-01
|
2004-06-30
|
0.28
|
2004-08-02
|
2004-03-31
|
0.28
|
2004-05-03
|
2003-12-30
|
0.28
|
2004-02-02
|
2003-10-01
|
0.28
|
2003-11-03
|
2003-07-01
|
0.28
|
2003-08-01
|
2003-04-02
|
0.28
|
2003-05-01
|
2002-12-31
|
0.28
|
2003-02-01
|
2002-10-02
|
0.28
|
2002-11-01
|
2002-07-02
|
0.28
|
2002-08-01
|
2002-04-03
|
0.28
|
2002-05-01
|
2002-01-02
|
0.28
|
2002-02-01
|
2001-10-03
|
0.28
|
2001-11-01
|
2001-07-03
|
0.28
|
2001-08-01
|
2001-04-04
|
0.28
|
2001-05-01
|
2001-01-03
|
0.28
|
2001-02-01
|
2000-10-04
|
0.25
|
2000-11-01
|
2000-07-05
|
0.25
|
2000-08-01
|
2000-04-05
|
0.25
|
2000-05-01
|
2000-01-05
|
0.25
|
2000-02-01
|
1999-09-29
|
0.22
|
1999-11-01
|
1999-06-30
|
0.22
|
1999-08-01
|
1999-03-30
|
0.22
|
1999-05-01
|
1999-01-06
|
0.43
|
1999-02-01
|
1998-09-30
|
0.39
|
1998-11-01
|
1998-06-30
|
0.39
|
1998-08-01
|
1998-04-01
|
0.39
|
1998-05-01
|
1997-12-30
|
0.39
|
1998-02-01
|
1997-10-01
|
0.38
|
1997-11-01
|
1997-07-01
|
0.38
|
1997-08-01
|
1997-04-02
|
0.38
|
1997-05-01
|
1996-12-31
|
0.76
|
1997-02-01
|
1996-10-02
|
0.75
|
1996-11-01
|
1996-07-02
|
0.75
|
1996-08-01
|
1996-04-02
|
0.75
|
1996-05-01
|
1996-01-03
|
0.75
|
1996-02-01
|
1995-10-04
|
0.74
|
1995-11-01
|
1995-07-05
|
0.74
|
1995-08-01
|
1995-04-03
|
0.74
|
1995-05-01
|
1994-12-30
|
0.74
|
1995-02-01
|
1994-10-03
|
0.73
|
1994-11-01
|
1994-06-27
|
0.73
|
1994-08-01
|
1994-03-25
|
0.73
|
1994-05-01
|
1994-01-03
|
0.73
|
1994-02-01
|
1993-09-27
|
0.72
|
1993-11-01
|
1993-06-28
|
0.72
|
1993-08-01
|
1993-03-29
|
0.72
|
1993-05-01
|
1993-01-04
|
0.72
|
1993-02-01
|
1992-09-28
|
0.69
|
1992-11-01
|
1992-06-26
|
0.69
|
1992-08-01
|
1992-03-30
|
0.69
|
1992-05-01
|
1991-12-27
|
0.69
|
1992-02-01
|
1991-09-30
|
0.60
|
1991-11-01
|
1991-06-28
|
0.60
|
1991-08-01
|
1991-04-01
|
0.60
|
1991-05-01
|
1990-12-28
|
0.60
|
1991-02-01
|
1990-10-01
|
0.53
|
1990-11-01
|
1990-06-29
|
0.53
|
1990-08-01
|
1990-04-02
|
0.53
|
1990-05-01
|
1989-12-29
|
0.53
|
1990-02-01
|
1989-09-19
|
0.50
|
1989-11-01
|
1989-06-30
|
0.50
|
1989-08-01
|
1989-04-03
|
0.50
|
1989-05-01
|
1988-12-30
|
0.50
|
1989-02-01
|
1988-10-03
|
0.42
|
1988-11-01
|
1988-06-27
|
0.42
|
1988-08-01
|
1988-03-25
|
0.42
|
1988-05-01
|
1988-01-04
|
0.42
|
1988-02-01
|
1987-09-28
|
0.35
|
1987-11-01
|
1987-06-26
|
0.35
|
1987-08-01
|
1987-03-30
|
0.70
|
1987-05-01
|
1986-12-26
|
0.70
|
1987-02-01
|
1986-09-29
|
0.55
|
1986-11-01
|
1986-06-27
|
0.55
|
1986-08-01
|
1986-03-31
|
0.55
|
1986-05-01
|
1985-12-07
|
0.47
|
1986-02-01
|
1985-09-30
|
0.47
|
1985-11-01
|
1985-06-08
|
0.47
|
1985-08-01
|
1985-03-09
|
0.47
|
1985-05-01
|
1984-12-08
|
0.40
|
1985-02-01
|
1984-10-01
|
0.40
|
1984-11-01
|
1984-06-29
|
0.40
|
1984-08-01
|
1984-04-02
|
0.40
|
1984-05-01
|
1983-12-30
|
0.30
|
1984-02-01
|
1983-10-03
|
0.30
|
1983-11-01
|
1983-07-01
|
0.30
|
1983-08-01
|
1983-01-03
|
0.52
|
1983-02-01
|
1982-10-04
|
0.52
|
1982-11-01
|
1982-07-02
|
0.52
|
1982-08-01
|
1982-04-04
|
0.60
|
1982-05-01
|
1982-04-02
|
0.52
|
1982-05-01
|
1982-01-04
|
0.46
|
1982-02-01
|
1981-10-05
|
0.46
|
1981-11-01
|
1981-07-06
|
0.46
|
1981-08-01
|
1981-04-06
|
0.46
|
1981-05-01
|
1981-01-05
|
0.40
|
1981-02-01
|
1980-10-06
|
0.40
|
1980-11-01
|
1980-06-30
|
0.40
|
1980-08-01
|
1980-03-28
|
0.40
|
1980-05-01
|
1979-12-28
|
0.36
|
1980-02-01
|
1979-10-05
|
0.36
|
1979-11-01
|
1979-06-29
|
0.36
|
1979-08-01
|
1979-04-02
|
0.36
|
1979-05-01
|
1978-12-29
|
0.31
|
1979-02-01
|
1978-10-02
|
0.31
|
1978-11-01
|
1978-06-30
|
0.31
|
1978-08-01
|
1978-03-31
|
0.31
|
1978-05-01
|
1977-12-30
|
0.28
|
1978-02-01
|
1977-10-03
|
0.28
|
1977-11-01
|
1977-06-27
|
0.28
|
1977-08-01
|
